Octreotide, Lanreotide, & Pasireotide - Advanced Prostate...

Advanced Prostate Cancer

11,259 members13,635 posts

Octreotide, Lanreotide, & Pasireotide

Nalakrats
Nalakrats

These 3 materials/compounds can be attached to Lu-177, and have an ability for binding to the Somatostatin Receptor of both Neuroendrocrine and Small Cell Pca and be somewhat effective---or these compounds by themselves can also be somewhat effective. This info is from a paper--that I do not have my finger on at the moment, but you can Google each compound with Lu-177, and read if interested.

Most of the work is coming out of Munich Germany, I believe.

Nalakrats

2 Replies
oldestnewest
Hidden
Hidden

BBruce just posted a link to this australian site.

theranostics.com.au/lutetiu...

University of Iowa is doing this, also, based on the European work.

The 177Lu is also being trialed for regular prostate cancer, with a different guidance system.

Nalakrats
Nalakrats in reply to Hidden

Funny--how the Germans got so far ahead of us on this! Thanks for the link.

Nalakrats

You may also like...